These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 17676319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.
    Kakuda TN, Van Solingen-Ristea R, Aharchi F, Smedt GD, Witek J, Nijs S, Vyncke V, Hoetelmans RM.
    J Clin Pharmacol; 2013 Jan; 53(1):41-50. PubMed ID: 23400742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
    Saari TI, Laine K, Neuvonen M, Neuvonen PJ, Olkkola KT.
    Eur J Clin Pharmacol; 2008 Jan; 64(1):25-30. PubMed ID: 17987285
    [Abstract] [Full Text] [Related]

  • 8. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.
    Inomata S, Nagashima A, Itagaki F, Homma M, Nishimura M, Osaka Y, Okuyama K, Tanaka E, Nakamura T, Kohda Y, Naito S, Miyabe M, Toyooka H.
    Clin Pharmacol Ther; 2005 Dec; 78(6):647-55. PubMed ID: 16338280
    [Abstract] [Full Text] [Related]

  • 9. Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
    Hynninen VV, Olkkola KT, Neuvonen PJ, Laine K.
    Eur J Clin Pharmacol; 2009 Jan; 65(1):89-95. PubMed ID: 18777173
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
    Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T, Walter-Sack I, Haefeli WE, Mikus G.
    Clin Pharmacol Ther; 2005 Jul; 78(1):25-33. PubMed ID: 16003289
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
    Niioka T, Uno T, Yasui-Furukori N, Shimizu M, Sugawara K, Tateishi T.
    Eur J Clin Pharmacol; 2006 Oct; 62(10):855-61. PubMed ID: 16915367
    [Abstract] [Full Text] [Related]

  • 15. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI, Laine K, Leino K, Valtonen M, Neuvonen PJ, Olkkola KT.
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [Abstract] [Full Text] [Related]

  • 16. The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.
    Wang G, Lei HP, Li Z, Tan ZR, Guo D, Fan L, Chen Y, Hu DL, Wang D, Zhou HH.
    Eur J Clin Pharmacol; 2009 Mar; 65(3):281-5. PubMed ID: 18982321
    [Abstract] [Full Text] [Related]

  • 17. Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism.
    Shi HY, Yan J, Zhu WH, Yang GP, Tan ZR, Wu WH, Zhou G, Chen XP, Ouyang DS.
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1131-6. PubMed ID: 20669013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.